Pharmacology Research Program
The Master of Science and Ph.D. degrees in Biomedical Sciences–Pharmacology provide substantial opportunity to conduct research in molecular targeting, drug design and drug delivery in developing new approaches to treat disease. The multidisciplinary program enrolls a select group of graduate students interested in research-based careers in pharmacology, and provides a balance of classroom and laboratory work involving faculty at NEOMED and Kent State University. Strong research focus exists in the areas of cardiovascular and metabolic diseases, neurodegenerative and blood brain barrier pharmacology. Interdisciplinary approaches to research and theoretical problems are strongly emphasized.
Faculty Researchers at NEOMED
Through the Biomedical Sciences-Pharmacology program, graduate students have the opportunity to work with one of the following faculty researchers at NEOMED:
Yeong-Renn Chen, Ph.D.
Oxygen free radicals, nitric oxide, oxidative postranslational modifications and mitochondrial biology in myocardial infarction.
John Y.L. Chiang, Ph.D.
Molecular cloning, expression and regulation of cytochrome P-450 genes; regulation of bile acid synthesis and cholesterol metabolism in the human liver.
William Chilian, Ph.D., FAHA, FCVS
Angiogenesis, arteriogenesis, regulation of coronary blood flow, heart failure, stem cells, regenerative medicine.
Altaf Darvesh, Ph.D.
Development of antioxidant and anti-inflammatory strategies for neoplastic an neurodegenerative diseases, as well as psychiatric disorders.
Vanessa Fitsanakis, Ph.D.
Sheila Fleming, Ph.D.
Parkinson’s disease, alpha-synuclein, motor and non-motor behavioral function.
Tariq Haqqi, Ph.D.
Muhammad Hossain, D.V.M., Ph.D.
Takhar Kasumov, Ph.D.
Mitochondrial function, lipoprotein metabolism, protein synthesis and degradation, metabolomics and proteomics.
Yoon-Kwang Lee, Ph.D.
Structure and regulation of nuclear hormone receptors.
Priya Raman, Ph.D.
Cellular and molecular mechanisms underlying cardiovascular complications associated with diabetes and obesity; atherosclerosis; leptin; Thrombospondin-1.
Prabodh Sadana, Ph.D.
Hormonal regulation of lipid metabolism.
Charles Thodeti, Ph.D., FAHA, FCVS
Mechanical control of integrin activation in capillary endothelial cells, signal transduction.
Liya Yin, M.D., Ph.D.
Lipid metabolism, atherosclerosis, regulation of coronary circulation, coronary collateral growth, stem cells in cardiovascular regeneration.
Min You, Ph.D.
Yanqiao Zhang, M.D.
Regulation of lipid and glucose metabolism under normal and disease conditions.